Active Peripheral Spondyloarthritis (pSpA)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Active Peripheral Spondyloarthritis (pSpA) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 3

NCT05206591

Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloa…

The purpose of this study is to investigate the efficacy and safety of subcutaneous (s.c) secukinumab in comparison with placebo for participants with two subty…

Location not specified0Started 2022-08-16

Treatment: Secukinumab, Placebo